Anti-carbamylated protein antibodies positivity and disease activity in Hispanic patients with established rheumatoid arthritis: An observational study.
David Vega MoralesMario Alberto Garza-ElizondoLeendert Adrianus TrouwKarina I Gonzalez-TorresErnesto Torres-LopezMiryam Eguia-BernalSalvador A Loredo-AlanisTayde Sarahí Gracia-AréchigaBrenda R Vazquez-FuentesDiana D Castañeda-MartinezMartha Mariana Castañeda-MartínezCésar Vidal Elizondo-SolísAndres Mendiola-JimenezMario C Salinas-CarmonaPablo Herrera-SandateJesus A Cardenas-de la GarzaGerardo E Rodriguez-SanchezDionicio Ángel Galarza-DelgadoPublished in: Modern rheumatology (2021)
Anti-CarP IgG antibodies are not associated to a higher disease activity in Hispanic patients with established RA. Our findings suggest that the clinical value of measuring anti-CarP antibodies in RA diminishes over time.